NRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors
Redox Biology · 2026-10 · 96 · 104352
DOI: 10.1016/j.redox.2026.104352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2026-10. Verfasst von Dichun Huang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Center for Inflammation Science and Systems Medicine, UF Scripps Institute for Biomedical Innovation and Technology…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIEHS NIH HHS, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Center for Inflammation Science and Systems Medicine, UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA; Department of Pharmacology and Toxicology, College…
- Department of Molecular Medicine, Center for Inflammation Science and Systems Medicine, UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA.
- Department of Molecular Medicine, Center for Inflammation Science and Systems Medicine, UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA; Genetics Graduate Interdisciplinary Program, Unive…
- Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, USA.
- Department of Molecular Medicine, Center for Inflammation Science and Systems Medicine, UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA; Department of Pharmacology and Therapeutics, Colle…
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Förderung
- NCI NIH HHS
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
- National Cancer Center
- National Institutes of Health
- University of Arizona Cancer Center
Zitieren
APA
Huang, D., Zhang, M., Stansfield, B. N., Ahmed, M., Xu, T., Alexander, L., Anandhan, A., Ma, M., Liu, P., Yang-Hartwich, Y., Fang, D., Chapman, E., Garcia, J. G. N., Wong, P. K., Ooi, A., & Zhang, D. D. (2026). NRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors. Redox Biology, 96, 104352. https://doi.org/10.1016/j.redox.2026.104352
Vancouver
Huang D, Zhang M, Stansfield BN, Ahmed M, Xu T, Alexander L, et al. NRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors. Redox Biology. 2026;96:104352. doi:10.1016/j.redox.2026.104352
BibTeX
@article{Huang2026,
author = {Huang, Dichun and Zhang, Mae and Stansfield, Ben N and Ahmed, Mona and Xu, Tianbao and Alexander, Lewis and Anandhan, Annadurai and Ma, Mengjiao and Liu, Pengfei and Yang-Hartwich, Yang and Fang, Deyu and Chapman, Eli and Garcia, Joe G N and Wong, Pak Kin and Ooi, Aikseng and Zhang, Donna D},
title = {NRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors},
journal = {Redox Biology},
year = {2026},
volume = {96},
pages = {104352},
doi = {10.1016/j.redox.2026.104352}
}
EUVIMED